Standout Papers
Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
A Panel of Four miRNAs Accurately Differentiates Malignant from Benign Indeterminate Thyroid Lesions on Fine Needle Aspiration
2012
Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
2013
Differing Phenotypes between Intraepithelial and Stromal Lymphocytes in Early-Stage Tongue Cancer
2007
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity
2008
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence
2009
Identification of Genes Differentially Expressed in Benign versus Malignant Thyroid Tumors
2008
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
2011 StandoutNobel
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients
2010
Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
2010 StandoutNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer
2005
The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature
2012
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer
2011
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Tumor-Infiltrating FOXP3 + T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
2008
Central Role of IFNγ–Indoleamine 2,3-Dioxygenase Axis in Regulation of Interleukin-12–Mediated Antitumor Immunity
2009
Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors.
2007
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
PD-1 Is a Regulator of NY-ESO-1-Specific CD8+ T Cell Expansion in Melanoma Patients
2009
Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine
2014
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
2015
Hallmarks of Cancer: The Next Generation
2011 Standout
Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways
2010
FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
2020
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability
2008
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
2008
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Combinatorial Cancer Immunotherapy
2006
Prognostic impact of tumour‐infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma
2008
Progress in human tumour immunology and immunotherapy
2001 Nature
Adaptive immunity maintains occult cancer in an equilibrium state
2007 Nature
mRNA expression of leukemia‐associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies
2003
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation
2012
Increased Regulatory T Cells Correlate With CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma Patients
2007
GSK's antigen-specific cancer immunotherapy programme: Pilot results leading to Phase III clinical development
2007
Strategies to overcome immune ignorance and tolerance
2002
About human tumor antigens to be used in immunotherapy
2008
Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity
2006
Polymeric Structure and Host Toll-like Receptor 4 Dictate Immunogenicity of NY-ESO-1 Antigen in Vivo
2011
Host tissue determinants of tumour immunity
2019
Induction of cellular and humoral immune responses to tumor cells and peptides in HLA‐A24 positive hormone‐refractory prostate cancer patients by peptide vaccination
2003
DNA, but not protein vaccine based on mutated BORIS antigen significantly inhibits tumor growth and prolongs the survival of mice
2007
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome
2007 StandoutNobel
A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients
2004
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma
2007
Clinical impact of tumor‐infiltrating lymphocytes for survival in stage II colon cancer
2010
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient
2008
Regulatory T Cells in Cancer
2010
The Human T Cell Response to Melanoma Antigens
2006
Regulatory T Cells and Immune Tolerance
2008 StandoutNobel
Thyroid tumor marker genomics and proteomics: Diagnostic and clinical implications
2010
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
2014
Naturally occurring B-cell responses to breast cancer
2003
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
2003 Standout
Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients
2007
Cancer immunoediting from immune surveillance to immune escape
2007
An immunodominant SSX-2–derived epitope recognized by CD4+ T cells in association with HLA-DR
2004
Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen
2006
Immunology and immunotherapy of colorectal cancer
2003
Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes
2016 StandoutNobel
Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?
2007
Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma
2009
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Expression of tumour-specific antigens underlies cancer immunoediting
2012 Nature
Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
2008
FN1, GALE, MET, and QPCT overexpression in papillary thyroid carcinoma: Molecular analysis using frozen tissue and routine fine‐needle aspiration biopsy samples
2010
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
2002
Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology
2015
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Tumor‐specific shared antigenic peptides recognized by human T cells
2002
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
2014
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses
2009 StandoutNobel
The impact of T‐cell immunity on ovarian cancer outcomes
2008
Immune infiltration in human tumors: a prognostic factor that should not be ignored
2009
ISCOMATRIX� adjuvant for antigen delivery
2004
Regulatory T cells and cancer
2007
Safety and Immunogenicity of Tyrosinase DNA Vaccines in Patients with Melanoma
2007
CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer
2009
Cancer testis antigen expression in gastrointestinal stromal tumors: New markers for early recurrence
2008
Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma
2009
Identification of specific autoantigens in Sjögren's syndrome by SEREX
2005
Identification of cytotoxic T‐lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4)
2007
Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses
2002
Tumor‐reactive CD8+ T‐cell responses after vaccination with NY‐ESO‐1 peptide, CpG 7909 and Montanide® ISA‐51: association with survival
2009
Human tumor antigens for cancer vaccine development
1999
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Regulatory T cells in cancer immunotherapy
2016 StandoutNobel
Identification of a cold receptor reveals a general role for TRP channels in thermosensation
2002 StandoutNatureNobel
In vivo antigen delivery by aSalmonella typhimurium type III secretion system for therapeutic cancer vaccines
2006
A TRP Channel that Senses Cold Stimuli and Menthol
2002 StandoutNobel
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
2017
Inducible expression of a prostate cancer‐testis antigen, SSX‐2, following treatment with a DNA methylation inhibitor
2007
Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
2009
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Spinning molecular immunology into successful immunotherapy
2002
Chromosomal Redistribution of Male-Biased Genes in Mammalian Evolution with Two Bursts of Gene Gain on the X Chromosome
2010
Regulatory T cells in tumor immunity
2010 StandoutNobel
Regulatory T cells in cancer immunotherapy
2014 StandoutNobel
Split T Cell Tolerance against a Self/Tumor Antigen: Spontaneous CD4+ but Not CD8+ T Cell Responses against p53 in Cancer Patients and Healthy Donors
2011
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Cancer Immunology
2008
Molecular Markers in Thyroid Fine-needle Aspiration Biopsy
2009
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells
2020
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
2007
Molecular genetics and diagnosis of thyroid cancer
2011
MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration
2012
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin
2007 StandoutNobel
T-cell responses of vaccinated cancer patients
2003
The evolution of gene expression levels in mammalian organs
2011 StandoutNatureNobel
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
An immune-active tumor microenvironment favors clinical response to ipilimumab
2011
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
2010 StandoutNobel
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Centralized Molecular Testing for Oncogenic Gene Mutations Complements the Local Cytopathologic Diagnosis of Thyroid Nodules
2014
MicroRNA Signature in Thyroid Fine Needle Aspiration Cytology Applied to “Atypia of Undetermined Significance” Cases
2011
BRAF Status of Follicular Variant of Papillary Thyroid Carcinoma and its Relationship to Its Clinical and Cytological Features
2010
Development of a MicroRNA-Based Molecular Assay for the Detection of Papillary Thyroid Carcinoma in Aspiration Biopsy Samples
2011
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function
2021
Recognition of a self major histocompatibility complex TL region product by gamma delta T-cell receptors.
1989 Nobel
Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF
2009
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens
2005
Autoreactive T Cells in Healthy Individuals
2004
A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytesin vitro
2008
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming
2007
Roles of regulatory T cells in cancer immunity
2016
Peptide Vaccine Induces Enhanced Tumor Growth Associated with Apoptosis Induction in CD8+ T Cells
2010
Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins.
2001
Regulatory T Cells and Human Disease
2020 StandoutNobel
The Three Es of Cancer Immunoediting
2004 Standout
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
2014
CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients
2005
Tumor-infiltrating NY-ESO-1–specific CD8 + T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
2010
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
2011
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Differential expression of cancer testis genes in histological subtypes of non-Hodgkin's lymphomas.
2003
ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction
2002
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Analysis of the B‐cell repertoire against antigens expressed by human neoplasms
2002
Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals
2008
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 StandoutNobel
Multiple roles for CD4+ T cells in anti‐tumor immune responses
2008
Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma.
2003
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas
2008
Influence of CD4+CD25+ Regulatory T Cells on Low/High-Avidity CD4+ T Cells following Peptide Vaccination
2006
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
CD4+T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production
2001
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
2009
An immunodominant SSX-2–derived epitope recognized by CD4+ T cells in association with HLA-DR
2004
Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage
2006
OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
2009
Epitope Landscape in Breast and Colorectal Cancer
2008 StandoutNobel
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy.
2010 StandoutNobel
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Recognition of Self Antigens by Skin-Derived T Cells with Invariant γδ Antigen Receptors
1991 StandoutScienceNobel
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
2007
Humoral immune responses to testis antigens in sera from patients with prostate cancer.
2006
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning
2004
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations
2002
Autoantibodies frequently detected in patients with aplastic anemia
2003
Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients
2006
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells
2002
Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes
1998
Identification of Cyclin B1 as a Shared Human Epithelial Tumor-Associated Antigen Recognized by T Cells
2001
Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity
2006
Adoptive T cell therapy using antigen-specific CD8+T cell clones for the treatment of patients with metastatic melanoma:In vivopersistence, migration, and antitumor effect of transferred T cells
2002
Intratumoral T-Cell Infiltrates and MHC Class I Expression in Patients with Stage IV Melanoma
2005
Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection
2007
OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer
2006
Immune Therapy for Cancer
2008
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccines.
2008
Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.
2001
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
2011
Comparative Analysis of Regulatory and Effector T Cells in Progressively Growing versus Rejecting Tumors of Similar Origins
2006
Dendritic Cell Surface Calreticulin Is a Receptor for NY-ESO-1: Direct Interactions between Tumor-Associated Antigen and the Innate Immune System
2006
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
MAD-CT-2 Identified as a Novel Melanoma Cancer-testis Antigen Using Phage Immunoblot Analysis
2007
Works of Yao‐Tseng Chen being referenced
CT7 (MAGE‐C1) antigen expression in normal and neoplastic tissues
2002
Diagnostic Usefulness of HBME1, Galectin-3, CK19, and CITED1 and Evaluation of Their Expression in Encapsulated Lesions With Questionable Features of Papillary Thyroid Carcinoma
2006
Diagnostic Usefulness of HBME1, Galectin-3, CK19, and CITED1 and Evaluation of Their Expression in Encapsulated Lesions With Questionable Features of Papillary Thyroid Carcinoma
2006
Microarray Analysis of Thyroid Nodule Fine-Needle Aspirates Accurately Classifies Benign and Malignant Lesions
2006
Cancer/testis (CT) antigens: Potential targets for immunotherapy
2009
Autoantibodies Against Cancer Antigens
2009
A103
1998
The SSX gene family: Characterization of 9 complete genes
2002
MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma
1997
Expression ofSSX genes in human tumors
1998
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
2001
Identification of cancer/testis genes by database mining and mRNA expression analysis
2002
Expression of Melan-A (MART1) in Benign Melanocytic Nevi and Primary Cutaneous Malignant Melanoma
1998
SSX: A multigene family with several members transcribed in normal testis and human cancer
1997
T311—An Anti-Tyrosinase Monoclonal Antibody for the Detection of Melanocytic Lesions in Paraffin Embedded Tissues
2000
NY‐ESO‐1: Review of an Immunogenic Tumor Antigen
2006
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma
2008
Antigens recognized by autologous antibody in patients with renal-cell carcinoma
1999
SEREX analysis of gastric cancer antigens
2000
Cancer/testis antigens, gametogenesis and cancer
2005 Standout
Humoral immune responses of cancer patients against “Cancer-Testis” antigen NY-ESO-1: Correlation with clinical events
1999
Characterization of human colon cancer antigens recognized by autologous antibodies
1998
NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy
2007
PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses.
2007
Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
2000
Seromic profiling of ovarian and pancreatic cancer
2010
Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.
2002
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
1997
Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer.
2004
Expression of MAGE-antigens in normal tissues and cancer
2000
Identification of cancer antigens in breast cancer by the SEREX expression cloning method
1999
Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.
2003
Intraepithelial CD8+tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
2005 Standout
A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens
1998
Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library
1998
Characterization of human colon cancer antigens recognized by autologous antibodies
1998
Immunomic analysis of human sarcoma
2003
CT10: A new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis
2000
Tla-region genes and their products
1987
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51
2002
Immunohistochemical and Molecular Analysis of Human Melanomas for Expression of the Human Cancer-Testis Antigens NY-ESO-1 and LAGE-1
2004
Serological cloning of a melanocyte rab guanosine 5'-triphosphate-binding protein and a chromosome condensation protein from a melanoma complementary DNA library.
2000
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele
2000
NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
2003
Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL
2000
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers
2000
Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
2002
Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma
2000
Survey of naturally occurring CD4 + T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses
2003